Search Site
  • 0
    My Cart

    Click Here to Find How Many Items You Have Added:)

    image loader

    Adding item(s) to cart......

Home >> Signaling Pathways >> GPCR/G protein >> Cannabinoid Receptor

Cannabinoid Receptor

The cannabinoid receptor (CB1 and CB2) is a member of G-protein coupled receptor which plays a significant role in physiologic processes such as cognitive and immune functions.

Products for  Cannabinoid Receptor

  1. Cat.No. Product Name Information
  2. GC10907 (±)-SLV 319

    (±)-SLV319; (±)-BMS-646256

     (±)-SLV 319 ((±)-SLV319) is the racemate of SLV319. (±)-SLV 319 Chemical Structure
  3. GC10028 (R)-SLV 319 CB1 receptor antagonist (R)-SLV 319 Chemical Structure
  4. GC63410 (Rac)-MRI-1867

    (Rac)-MRI-1867

     (Rac)-MRI-1867 ((Rac)-MRI-1867, compound 6b) is a cannabinoid receptor type 1 (CB1R)/iNOS antagonist, with a Ki of 5.7 nM for CB1R. (Rac)-MRI-1867 Chemical Structure
  5. GC10753 (S)-SLV 319

    Ibipinabant|BMS 646256|JD 5001

     (S)-SLV 319 (SLV319) is a potent, selective and orally active antagonist of cannabinoid CB1 receptor, with a Ki of 7.8 nM. (S)-SLV 319 Chemical Structure
  6. GC16403 2-Arachidonoyl Glycerol

    2-AG

    An endogenous agonist of the cannabinoid (CB) receptors CB1 and CB2

     2-Arachidonoyl Glycerol Chemical Structure
  7. GC16196 2-Palmitoylglycerol

    Glycerol-β-palmitate, 2-Hexadecanoyl Glycerol, 2-Monopalmitin, 2-PG

     Endogenous fatty acid glycerol ester 2-Palmitoylglycerol Chemical Structure
  8. GC17100 4-Quinolone-3-Carboxamide CB2 Ligand

    4Q3C CB2 Ligand

     ligand of the CB2 receptor 4-Quinolone-3-Carboxamide CB2 Ligand Chemical Structure
  9. GC15850 4-Quinolone-3-Carboxamide Furan CB2 Agonist

    4Q3C CB2 Agonist

     4-Quinolone-3-Carboxamide Furan CB2 Agonist is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor with a Ki of 8.5 nM. 4-Quinolone-3-Carboxamide Furan CB2 Agonist Chemical Structure
  10. GC18199 A-836339 A-836339 is a synthetic cannabinoid (CB) which has a higher affinity for the peripheral CB2 receptor (Ki = 0.64 nM) over the central CB1 receptor (Ki = 270 nM). A-836339 Chemical Structure
  11. GC71409 AEF0117 AEF0117 is a signaling-specific inhibitor of the cannabinoid receptor 1 (CB1-SSi). AEF0117 Chemical Structure
  12. GC16480 AM 281 A CB1 antagonist AM 281 Chemical Structure
  13. GC62835 AM-6538 AM6538 is a long-acting, high affinity and pseudo-irreversible cannabinoid (CB) antagonist. AM-6538 Chemical Structure
  14. GC15414 AM1241 Cannabinoid CB2 receptor agonist,potent and selective AM1241 Chemical Structure
  15. GC15717 AM251 AM251 is a cannabinoid receptor type 1 (CB1) antagonist with an IC50 of 8nM and a G protein-coupled receptor 55 (GPR55) agonist with an EC50 of 39nM. AM251 Chemical Structure
  16. GC15093 AM4113

    AM4113

     AM4113 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3, inhibits CB1 in vivo with an IC50 of 25.5 nM. AM4113 Chemical Structure
  17. GC10147 AM630

    6-Iodopravodoline

    An inverse agonist at CB2 and partial agonist at CB1 receptors

     AM630 Chemical Structure
  18. GC14661 AM6545 CB1 selective neutral antagonist AM6545 Chemical Structure
  19. GC35339 Anandamide

    AEA, Anandamide

     An immune modulator in the central nervous system Anandamide Chemical Structure
  20. GC18435 Arachidonoyl 2'-Chloroethylamide

    ACEA, 2'chloroAEA

     A potent and selective CB1 receptor agonist Arachidonoyl 2'-Chloroethylamide Chemical Structure
  21. GC16826 Arachidonoyl amide

    Arachidonamide,Arachidonic Acid amide

     CB1 receptor agonist Arachidonoyl amide Chemical Structure
  22. GC18097 Arachidonoyl Serinol CB1 receptor agonist Arachidonoyl Serinol Chemical Structure
  23. GC11849 Arachidonyl serotonin

    AA5HT

     Arachidonyl serotonin (Arachidonyl serotonin; AA-5-HT) is a potent fatty acid amide hydrolase (FAAH) inhibitor with an IC50 value of 1~12 μM. Arachidonyl serotonin Chemical Structure
  24. GC73831 ART26.12 ART26.12 is an orally active FABP5 inhibitor with anti-cannabinoid properties. ART26.12 Chemical Structure
  25. GC10205 Arvanil

    NVanillylarachidonamide

     Cannabinoid CB1 and vanilloid TRPV1 (VR1) agonist Arvanil Chemical Structure
  26. GC14115 AVE-1625

    Drinabant

     AVE-1625 (AVE1625) is an orally active CB1 receptor antagonist. AVE-1625 Chemical Structure
  27. GC62855 AZD1940 AZD1940 is an orally active, high affinity cannabinoid CB1/CB2 receptor agonist with pKi values of 7.93 and 9.06 for human CB1R and CB2R, respectively. AZD1940 Chemical Structure
  28. GC61778 BAY 38-7271 BAY 38-7271 is selective and highly potent and cannabinoid CB1/CB2 receptor agonist, with Kis of 1.85 nM and 5.96 nM for recombinant human CB1 receptor and CB2 receptor, respectively. BAY 38-7271 Chemical Structure
  29. GC19060 Bay 59-3074 Bay 59-3074 is a novel, selective CB1/CB2 receptor partial agonist with Ki values of 48.3 and 45.5 nM at human CB1 and CB2 receptors respectively . Bay 59-3074 Chemical Structure
  30. GC11376 BML-190

    BML-190, Indomethacin Morpholinylamide, LM-4131

     CB2 receptor ligand BML-190 Chemical Structure
  31. GC66030 CB1 agonist 1 CB1 agonist 1 (compound 22) is an agonist of CB1. CB1 agonist 1 shows affinity to CB1 receptor with an pIC50 value of 5.7. CB1 agonist 1 can be used for the research of brain disorders. CB1 agonist 1 Chemical Structure
  32. GC31306 CB1 antagonist 1 CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions. CB1 antagonist 1 Chemical Structure
  33. GC30935 CB1-IN-1 CB1-IN-1 (BPRCB1184) is a peripherally restricted CB1R antagonist, with Ki of 0.3 nM and 21 nM for CB1R (EC50 = 3 nM) and CB2R, respectively. CB1-IN-1 Chemical Structure
  34. GC71002 CB1/2 agonist 1 CB1/2 agonist 1 is a potent and cross the blood-brain barrier CB1/2 agonist with EC50s of 56.15, 11.63 nM for CB1R and CB2R, respectively. CB1/2 agonist 1 Chemical Structure
  35. GC71112 CB1/2 agonist 3 CB1/2 agonist 3 (compound 52), a potent non-selective cannabinoid ligand, is a CB1/CB2 (cannabinoid receptor) competitive agonist. CB1/2 agonist 3 Chemical Structure
  36. GC71118 CB1R antagonist 1 CB1R antagonist 1 Chemical Structure
  37. GC70732 CB2 modulator 1 CB2 modulator 1 (compound 130) is a potent CB2 modulator. CB2 modulator 1 Chemical Structure
  38. GC71206 CB2R antagonist 3 CB2R antagonist 3 is a selective antagonist of cannabinoid type 2 receptor (CB2R). CB2R antagonist 3 Chemical Structure
  39. GC33756 CB2R-IN-1 CB2R-IN-1 is a potent cannabinoid CB2 receptor inverse agonist with a Ki of 0.9 nM. CB2R-IN-1 Chemical Structure
  40. GC18110 COR 170 inverse agonist of CB2 receptors COR 170 Chemical Structure
  41. GC17205 CP-945598 HCl

    Otenabant

     CP-945598 HCl is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor. CP-945598 HCl Chemical Structure
  42. GC50579 Ec2la Ec2la is an orally active cannabinoid type-2 receptors (CB2Rs) positive allosteric modulator. Ec2la Chemical Structure
  43. GC70224 GW 833972A GW 833972A is a selective CB2 receptor agonist. GW 833972A Chemical Structure
  44. GC72818 GW405833 hydrochloride

    L768242 hydrochloride

     GW-405833 (L768242) drochloride is a potent, selective cannabinoid receptor 2 (CB2) agonist with an EC50 of 50.7 nM. GW405833 hydrochloride Chemical Structure
  45. GC11760 GW842166X Cannabinoid receptor agonist GW842166X Chemical Structure
  46. GC17133 Hemopressin (human, mouse) CB1 receptor inverse agonist; endogenous peptide substrate for endopeptidase 24.15 (ep24.15), neurolysin (ep24.16) and ACE Hemopressin (human, mouse) Chemical Structure
  47. GC17116 Hemopressin (rat) selective CB1 receptor inverse agonist Hemopressin (rat) Chemical Structure
  48. GC13965 HU 308

    CB2-receptor agonist

     HU 308 Chemical Structure
  49. GC13660 JD5037 inverse agonist at CB1 receptors JD5037 Chemical Structure
  50. GC16644 JTE 907 cannabinoid CB2 receptor inverse agonist JTE 907 Chemical Structure
  51. GC10885 JWH 133 An Analytical Reference Standard JWH 133 Chemical Structure
  52. GC18496 Leelamine (hydrochloride)

    Dehydroabietylamine

     Leelamine is a diterpene molecule whose name derives from the Sanskrit word leela which means 'play'- It has weak affinity for the human central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 uM. Leelamine (hydrochloride) Chemical Structure
  53. GC50273 LEI 101 hydrochloride Potent and selective CB2 partial agonist; orally biovailable LEI 101 hydrochloride Chemical Structure
  54. GC12538 LH 21 silent CB1 antagonist LH 21 Chemical Structure
  55. GC13318 LY 320135 CB1 receptor antagonist/inverse agonist LY 320135 Chemical Structure
  56. GC19231 LY2828360 LY2828360 is a slowly acting but efficacious G protein-biased cannabinoid (CB2) agonist, inhibiting cAMP accumulation and activating ERK1/2 signaling. LY2828360 Chemical Structure
  57. GC12420 MAFP

    MAFP

    cPLA2 and iPLA2 inhibitor, potent FAAH inhibitor

     MAFP Chemical Structure
  58. GC36579 MDA 19 MDA 19 Chemical Structure
  59. GC15788 MJ 15 CB1 receptor antagonist MJ 15 Chemical Structure
  60. GC11453 ML-191

    CCG-152883,CID-23612552

     inhibitor of LPI-induced phosphorylation of ERK1/2 ML-191 Chemical Structure
  61. GC14626 MM-22

    biotinylated anandamide analog acts as a probe for visualizing the accumulation and intracellular trafficking of anandamide

     MM-22 Chemical Structure
  62. GC71262 Monlunabant Monlunabant ((S)-MRI-1891) is a solid dispersions compound, as well as a cannabinoid CB1 receptor inhibitor. Monlunabant Chemical Structure
  63. GC70724 MRL-650 MRL-650 (CB1 inverse agonist 1) is a highly potent, orally active, and specific inverse agonist of CB1 receptor with IC50s of 7.5 nM and 4100 nM for CB1 and CB2 receptors, respectively. MRL-650 Chemical Structure
  64. GC14750 N-Arachidonylglycine

    N-Arachidonyl Glycine, NAGly

    Endogenous anandamide-like compound

     N-Arachidonylglycine Chemical Structure
  65. GC31536 N-Oleoyl glycine

    A putative substrate for peptidyl glycine αamidating enzyme

     N-Oleoyl glycine Chemical Structure
  66. GC18041 NESS 0327 extremely potent cannabinoid (CB) receptor antagonist NESS 0327 Chemical Structure
  67. GC13267 NIDA 41020 CB1 receptor antagonist NIDA 41020 Chemical Structure
  68. GC69562 Nimacimab

    RYI-018

    Nimacimab (RYI-018) is a negative allosteric modulating monoclonal antibody that targets the CB1 receptor. Nimacimab can be used in research on metabolic diseases.

     Nimacimab Chemical Structure
  69. GC17699 O-1821

    Cannabidiorcin, Cannabidiorcol, Cannabidiorocol, CBD-C1, CBDO

    cannabidiol analog with close structural similarity to O-1918 which is a selective antagonist of abnormal cannabidiol

     O-1821 Chemical Structure
  70. GC13847 O-1918

    endothelial anandamide receptor antagonist

     O-1918 Chemical Structure
  71. GC14042 Oleamide

    cis9Octadecenamide

     CB1 cannabinoid receptor agonist Oleamide Chemical Structure
  72. GC30966 Olivetol

    5-n-Amylresorcinol, 5-Pentylresorcinol

     Olivetol is a naturally phenol found in lichens and produced by certain insects, acting as a competitive inhibitor of the cannabinoid receptors CB1 and CB2. Olivetol Chemical Structure
  73. GC30504 Olorinab (APD 371)

    APD 371

     Olorinab (APD 371) (APD 371) is a highly potent, selective and fully efficacious cannabinoid receptor type 2 (CB2) agonist, with an EC50 of 6.2 nM for hCB2. Olorinab (APD 371) Chemical Structure
  74. GC10664 Org 27569 Cannabinoid CB1 receptor allosteric modulator Org 27569 Chemical Structure
  75. GC10843 Otenabant Otenabant Chemical Structure
  76. GC16548 Palmitoylisopropylamide

    PIA

     FAAH inhibitor Palmitoylisopropylamide Chemical Structure
  77. GC14461 PB-22

    QUPIC

     Synthetic cannabinoid PB-22 Chemical Structure
  78. GC16171 PF 514273 CB1 receptor antagonist PF 514273 Chemical Structure
  79. GC70955 PGN36 PGN36 (Compound 18) is a selective cannabinoid CB2 receptor (CB2R) antagonist with a Ki of 0.09 µM. PGN36 Chemical Structure
  80. GC50387 PM 226 Potent and selective CB2 receptor agonist; BBB permeable; neuroprotective PM 226 Chemical Structure
  81. GC12920 Pregnenolone

    NSC 1616, NSC 18158, 3β-hydroxy-5-Pregnen-20-one, Δ5-Pregnenolone

     steroid hormone Pregnenolone Chemical Structure
  82. GC36963 Pregnenolone monosulfate

    3β-Hydroxy-5-pregnen-20-one monosulfate

     Pregnenolone monosulfate (3β-Hydroxy-5-pregnen-20-one monosulfate) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone monosulfate Chemical Structure
  83. GC44680 Pregnenolone sulfate (sodium salt)

    3β-Hydroxy-5-pregnen-20-one monosulfate sodium

     Pregnenolone sulfate (sodium salt) (3β-Hydroxy-5-pregnen-20-one monosulfate sodium) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone sulfate (sodium salt) Chemical Structure
  84. GC65106 Pregnenolone-d4-1 Pregnenolone-d4-1 Chemical Structure
  85. GC50435 PSB CB5

    CID-85469571

     Selective GPR18 antagonist PSB CB5 Chemical Structure
  86. GC74008 PSB-KK1415 PSB-KK1415 is a selective agonist for human orphan G protein-coupled receptor GPR18, with EC50 of 19.1 nM. PSB-KK1415 Chemical Structure
  87. GC50143 PSNCBAM-1 Negative allosteric modulator of CB1 receptors PSNCBAM-1 Chemical Structure
  88. GC14177 R-1 Methanandamide Phosphate

    R-1MAP,(R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide Phosphate

     CB1 receptor agonist R-1 Methanandamide Phosphate Chemical Structure
  89. GC13190 R-Palmitoyl-(1-methyl) Ethanolamide

    R-1 PMA

     synthetic analog of palmitoyl ethanolamide (PEA) R-Palmitoyl-(1-methyl) Ethanolamide Chemical Structure
  90. GC17259 Rimonabant

    SR141716

     CB1 receptor antagonist Rimonabant Chemical Structure
  91. GC16466 Rimonabant hydrochloride A potent and selective CB1 receptor antagonist Rimonabant hydrochloride Chemical Structure
  92. GC63617 RTICBM-189 RTICBM-189 is a potent, brain-penetrant allosteric modulator of the cannabinoid type-1 (CB1) receptor with a pIC50 of 7.54 in Ca2+ mobilization assay. RTICBM-189 Chemical Structure
  93. GC66413 RVD-Hpα TFA RVD-Hpα TFA is the N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. RVD-Hpα TFA increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro. RVD-Hpα TFA also high affinity CB2 positive allosteric modulator (Ki=50 nM). RVD-Hpα TFA Chemical Structure
  94. GC13605 S-1 Methanandamide

    (S)-(−)-Arachidonyl-1'-Hydroxy-2'-Propylamide

     CB1 receptor ligand S-1 Methanandamide Chemical Structure
  95. GC12868 S-2 Methanandamide

    (S)-(+)-Arachidonyl-2'-Hydroxy-1'-Propylamide

     potent CB1 receptor agonist S-2 Methanandamide Chemical Structure
  96. GC67972 S-777469 S-777469 Chemical Structure
  97. GC50271 SCH 336

    SCH-225336

     Highly potent and selective CB2 inverse agonist SCH 336 Chemical Structure
  98. GC10032 SR 144528

    SR144528

     CB2 receptor inverse agonist SR 144528 Chemical Structure
  99. GC15574 Taranabant

    MK-0364

     A CB1 receptor inverse agonist Taranabant Chemical Structure
  100. GC37737 Taranabant ((1R,2R)stereoisomer)

    MK0364 (1R,2R)stereoisomer

     Taranabant (1R,2R)stereoisomer is the R-enantiomer of Taranabant. Taranabant ((1R,2R)stereoisomer) Chemical Structure
  101. GC37738 Taranabant racemate

    MK-0364 racemate

     Taranabant racemate (MK-0364 racemate) is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor extracted from patent WO 2004048317 A1. Taranabant racemate Chemical Structure

Items 1 to 100 of 111 total

per page
  1. 1
  2. 2

Set Descending Direction